USANA HEALTH SCIENCES INC
For the period ended Jul 4, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 4, 2026 · Filed Aug 13, 2026
USNA$13.10-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
(in thousands)
For the six months ended June 28, 2025
| Common stock · Additional paid-in capital · Retained earnings · Accumulated other comprehensive income (loss) · Total stockholders' equity attributable to USANA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Value | |||||||||
| Balance at December 28, 2024 | 19,064 | $19 | $75,816 | $478,944 | $(22,670) | $532,109 | |||
| Net earnings attributable to USANA | 19,057 | 19,057 | |||||||
| Other comprehensive income (loss), net of tax | 3,321 | 3,321 | |||||||
| Equity-based compensation expense | 6,502 | 6,502 | |||||||
| Common stock repurchased and retired | (927) | (1) | (3,753) | (23,984) | (27,738) | ||||
| Common stock issued under equity award plans | 125 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (2,191) | (2,191) | |||||||
| Balance at June 28, 2025 | 18,262 | $18 | $76,374 | $474,017 | $(19,349) | $531,060 | |||
For the six months ended July 4, 2026
| Common stock · Additional paid-in capital · Retained earnings · Accumulated other comprehensive income (loss) · Total stockholders' equity attributable to USANA | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Value | ||||||||
| Balance at January 3, 2026 | 18,281 | $18 | $83,544 | $465,720 | $(16,178) | $533,104 | ||
| Net loss attributable to USANA | (13,867) | (13,867) | ||||||
| Other comprehensive income (loss), net of tax | 2,502 | 2,502 | ||||||
| Equity-based compensation expense | 6,858 | 6,858 | ||||||
| Common stock issued under equity award plans | 182 | — | — | |||||
| Tax withholding for net-share settled equity awards | (2,291) | (2,291) | ||||||
| Balance at July 4, 2026 | 18,463 | $18 | $88,111 | $451,853 | $(13,676) | $526,306 | ||
For the three months ended June 28, 2025
| Common stock · Additional paid-in capital · Retained earnings · Accumulated other comprehensive income (loss) · Total stockholders' equity attributable to USANA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Value | |||||||||
| Balance at March 29, 2025 | 18,786 | $19 | $74,867 | $477,628 | $(22,752) | $529,762 | |||
| Net earnings attributable to USANA | 9,655 | 9,655 | |||||||
| Other comprehensive income (loss), net of tax | 3,403 | 3,403 | |||||||
| Equity-based compensation expense | 3,622 | 3,622 | |||||||
| Common stock repurchased and retired | (528) | (1) | (2,091) | (13,266) | (15,358) | ||||
| Common stock issued under equity award plans | 4 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (24) | (24) | |||||||
| Balance at June 28, 2025 | 18,262 | $18 | $76,374 | $474,017 | $(19,349) | $531,060 | |||
For the three months ended July 4, 2026
| Common stock · Additional paid-in capital · Retained earnings · Accumulated other comprehensive income (loss) · Total stockholders' equity attributable to USANA | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Value | ||||||||
| Balance at April 4, 2026 | 18,457 | $18 | $84,733 | $473,235 | $(14,436) | $543,550 | ||
| Net loss attributable to USANA | (21,382) | (21,382) | ||||||
| Other comprehensive income (loss), net of tax | 760 | 760 | ||||||
| Equity-based compensation expense | 3,404 | 3,404 | ||||||
| Common stock issued under equity award plans | 6 | — | — | |||||
| Tax withholding for net-share settled equity awards | (26) | (26) | ||||||
| Balance at July 4, 2026 | 18,463 | $18 | $88,111 | $451,853 | $(13,676) | $526,306 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.